* We recommend a score >= 0.08 for meaningful Gene-Disease associations

GeneID	Gene_Symbol	DisGeNet_diseaseID	Disease_name	DisGeNet score	DisGeNet_sourceDB
1434	CSE1L	C2239176	Liver carcinoma	0.00300763924902685	BEFREE;LHGDN
1434	CSE1L	C0041296	Tuberculosis	0.0019230874894917	BEFREE
1434	CSE1L	C0029925	Ovarian Carcinoma	0.0010989071368524	BEFREE
1434	CSE1L	C0750927	Apraxia, Developmental Verbal	0.0008241803526393	BEFREE
1434	CSE1L	C0678222	Breast Carcinoma	0.0008241803526393	BEFREE
1434	CSE1L	C0699790	Colon Carcinoma	0.0008241803526393	BEFREE
1434	CSE1L	C0027627	Neoplasm Metastasis	0.0008241803526393	BEFREE
1434	CSE1L	C0006142	Malignant neoplasm of breast	0.0008241803526393	BEFREE
1434	CSE1L	C0009402	Colorectal Carcinoma	0.0008241803526393	BEFREE
1434	CSE1L	C1527249	Colorectal Cancer	0.0008241803526393	BEFREE
1434	CSE1L	C0007102	Malignant tumor of colon	0.0008241803526393	BEFREE
1434	CSE1L	C0346429	Multiple malignancy	0.0005494535684262	BEFREE
1434	CSE1L	C0001430	Adenoma	0.0005494535684262	BEFREE
1434	CSE1L	C0596263	Carcinogenesis	0.0005494535684262	BEFREE
1434	CSE1L	C0221002	Hyperparathyroidism, Primary	0.0005494535684262	BEFREE
1434	CSE1L	C0679362	Tuberculosis, extrapulmonary	0.0005494535684262	BEFREE
1434	CSE1L	C1140680	Malignant neoplasm of ovary	0.0005494535684262	BEFREE
1434	CSE1L	C1519670	Tumor Angiogenesis	0.0002747267842131	BEFREE
1434	CSE1L	C0268621	Hepatic methionine adenosyltransferase deficiency	0.0002747267842131	BEFREE
1434	CSE1L	C0686619	Secondary malignant neoplasm of lymph node	0.0002747267842131	BEFREE
1434	CSE1L	C0751396	Well Differentiated Oligodendroglioma	0.0002747267842131	BEFREE
1434	CSE1L	C0936223	Metastatic Prostate Carcinoma	0.0002747267842131	BEFREE
1434	CSE1L	C1282496	Metastasis from malignant tumor of prostate	0.0002747267842131	BEFREE
1434	CSE1L	C1302401	Adenoma of large intestine	0.0002747267842131	BEFREE
1434	CSE1L	C0553694	Oropharyngeal disorders	0.0002747267842131	BEFREE
1434	CSE1L	C0553580	Ewings sarcoma	0.0002747267842131	BEFREE
1434	CSE1L	C0549473	Thyroid carcinoma	0.0002747267842131	BEFREE
1434	CSE1L	C1512409	Hepatocarcinogenesis	0.0002747267842131	BEFREE
1434	CSE1L	C0025202	melanoma	0.0002747267842131	BEFREE
1434	CSE1L	C0003873	Rheumatoid Arthritis	0.0002747267842131	BEFREE
1434	CSE1L	C0006413	Burkitt Lymphoma	0.0002747267842131	BEFREE
1434	CSE1L	C0007134	Renal Cell Carcinoma	0.0002747267842131	BEFREE
1434	CSE1L	C0017636	Glioblastoma	0.0002747267842131	BEFREE
1434	CSE1L	C0017638	Glioma	0.0002747267842131	BEFREE
1434	CSE1L	C0021367	Mammary Ductal Carcinoma	0.0002747267842131	BEFREE
1434	CSE1L	C0022602	Actinic keratosis	0.0002747267842131	BEFREE
1434	CSE1L	C0023418	leukemia	0.0002747267842131	BEFREE
1434	CSE1L	C0345904	Malignant neoplasm of liver	0.0002747267842131	BEFREE
1434	CSE1L	C0028945	oligodendroglioma	0.0002747267842131	BEFREE
1434	CSE1L	C0041316	Lymph Node Tuberculosis	0.0002747267842131	BEFREE
1434	CSE1L	C0079731	B-Cell Lymphomas	0.0002747267842131	BEFREE
1434	CSE1L	C0079744	Diffuse Large B-Cell Lymphoma	0.0002747267842131	BEFREE
1434	CSE1L	C0242621	Isochromosomes	0.0002747267842131	BEFREE
1434	CSE1L	C0262587	Parathyroid Adenoma	0.0002747267842131	BEFREE
1434	CSE1L	C0279000	Liver and Intrahepatic Biliary Tract Carcinoma	0.0002747267842131	BEFREE
1434	CSE1L	C0338106	Adenocarcinoma of colon	0.0002747267842131	BEFREE